Procter & Gamble Health Ltd - 500126 - Communication To Shareholders In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited- Final Dividend 2020-21
Company has communicated to the shareholders regarding deduction of tax at source (TDS) on the amount of Dividend income from Procter & Gamble Health Limited- final dividend 2020-21 Procter & Gamble Health Ltd - 500126 - Dates Of Book Closure For Purpose Of Annual General Meeting And Payment Of Dividend
We would like to inform you that the Register of Members and Share Transfer books shall remain closed from Friday, November 05, 2021, to Thursday, November 11, 2021 (both days inclusive) for the purposes of Annual General Meeting and payment of dividend for the year ended June 30, 2021, if approved by members at the 54th Annual General Meeting. Kindly take the same on record and oblige. Procter & Gamble Health Ltd - 500126 - Intimation Of 54Th Annual General Meeting And Dates Of Book Closure
We would like to inform you that the 54th Annual General Meeting of the Company is to be held on Thursday, November 11, 2021 through Video Conferencing/Other Audio-visual means, in compliance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India due to the current COVID-19 pandemic. We would further like to inform you that the Register of Members and Share Transfer books shall remain closed from Friday, November 05, 2021, to Thursday, November 11, 2021 (both days inclusive) for the purposes of Annual General Meeting and payment of dividend for the year ended June 30, 2021, if approved by members at the 54th Annual General Meeting. The notice convening the 54th Annual General Meeting of the Company will be provided in due course of time. Kindly take the same on record and oblige.
Wall St falls on worries over slowing economic recovery, Dow slumps over 250 pts
Amgen Inc and Merck & Co dropped about 2.5% each as the drugmakers dragged down the Dow Jones index, after Morgan Stanley cut its rating on the stocks to ?equal-weight? from ?overweight? Procter & Gamble Health Ltd - 500126 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed the annual secretarial compliance report for the year ended June 30, 2021, in line with SEBI Circular No. CIR/CFD/CMD1//27/2019 dated February 8, 2019. Kindly take the same on record and oblige. Procter & Gamble Health Ltd - 500126 - Appointment of Company Secretary and Compliance Officer
This has reference to the stock exchange disclosure dated August 26,2021, on the captioned subject, there was an inadvertent error in the brief profile of Ms. Zeal Shah. The revised intimation shall read as follows: In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that, the Board of directors at their meeting held today have appointed Ms. Zeal Shah as the Company Secretary of the Company with immediate effect .i.e. effective August 26,2021. Brief Profile of Ms. Shah is as below: Ms. Zeal Shah is a Law graduate and is an Associate Member of the Institute of Company Secretaries of India (ACS 52286). Ms. Shah has a work experience of 4 years in the field of Corporate & Securities Laws. Presently, she is the Compliance Officer of the Company under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Prohibition of Insider Trading) Regulations, 2015. Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company, at its meeting held today, have appointed Dr. Elizabeth Desmond as an Additional (Non-Executive) Director of the Company with effect from allotment of Director Identification Number by the Ministry of Corporate Affairs. Dr. Elizabeth Desmond will hold office as Additional Director up to the ensuing 54th Annual General Meeting. She does not hold any shares in the Company and is not related to any of the Directors of the Company. Kindly take the same on record. Procter & Gamble Health Ltd - 500126 - Appointment of Company Secretary and Compliance Officer
In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that, the Board of directors at their meeting held today have appointed Ms. Zeal Shah as the Company Secretary of the Company with immediate effect. Brief Profile of Ms. Shah is as below: Ms. Zeal Shah is a Commerce and a Law graduate, she is an Associate Member of the Institute of Company Secretaries of India (ACS 52286). Ms. Shah has a work experience of 4 years in the field of Corporate & Securities Laws. Presently, she is the Compliance Officer of the Company under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Prohibition of Insider Trading) Regulations, 2015. Kindly take the same on record and oblige. Q1FY22 Quarterly Result Announced for Procter & Gamble Health Ltd.
Highlights: Sales of Rs 990.8 crore and PAT of Rs 176 .8 crore for year ended June 30, 2021 Sales for the quarter up by +40% The company has recorded a strong performance with sales of Rs 281 Crores in the Quarter ending June 30th, up by +40% Vs year ago in a tough environment backed by a sustained demand for our trusted quality vitamins, minerals and supplements. The company recorded sales of Rs 990.8 crore for the twelve-month fiscal year ending 30th June 2021. Results for the fiscal are not comparable Vs 1,329 Crore sales for the eighteen months period last year ending 30th June 2020. Profit After Tax (PAT) for the year ended 30th June 2021 is Rs 176.8 crores against Rs 254.08 crores in the previous 18 months fiscal year ended 30th June 2020. Milind Thatte, Managing Director, Procter & Gamble Health Limited said, Given the uncertainty still presented by the pandemic, we continue to work towards protecting the health and safety of our employees and partners, ensuring uninterrupted supplies of our vitamins, minerals, supplements and medicinal products for our patients and consumers, and on supporting communities and relief efforts. As a part of the 'P& G Suraksha India' Covid-19 relief program, we contributed to the donation of 10 lakh vaccine doses for 5 lakh citizens in partnership with state governments and local authorities. We continue to invest in public health in India through flagship CSR program 'SEHAT' (meaning health). Under SEHAT, we recently announced a 3- year collaboration with Tata Trust for 'Yes To POSHAN', a new initiative which aims to advance the nutritional status of women and children at grassroots." Result PDF